Cell Engineering Overview

Principles

Definition

Cell engineering is an interdisciplinary research field focused on the targeted manipulation and modification of cellular components, pathways, and functions. This approach investigates how engineered cells can be designed and utilized for specific biological, therapeutic, or biotechnological applications, enabling the development of novel cellular behaviors and systems.

Ontological type

Core Methods

Therapeutic Applications

Design Principles

Key developments

Key Figures

Culture and Genetic Engineering era

Gail R. Martin[1], affiliated with University of California, San Francisco[3] and Baylor College of Medicine[4], contributed during the Culture and Genetic Engineering era. Gail R. Martin[1] described Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells[5], a breakthrough that established defined culture environments and enabled scalable mammalian cell work in this era. Robert H. Miller[2], affiliated with University of California, San Francisco[3] and Baylor College of Medicine[4], advanced neural cell culture research during this era. Robert H. Miller[2]'s 1983 paper, A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium[6], showed that culture conditions can direct glial differentiation and underscored the need for controlled culture systems in neural tissue engineering of the era.

Biomaterials-Enabled Tissue Engineering era

Daniel Scherman [1], affiliated with Université Paris-Sud [3] and Collège de France [4] during the Biomaterials-Enabled Tissue Engineering era, helped lay groundwork at the intersection of biomaterial cues and cellular gene transfer. His key contribution is the 1995 paper 'A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine' [7], which introduced polyethylenimine as a versatile non-viral vector for gene transfer in culture and in vivo, a foundational tool for directing cell behavior in scaffolded tissues. Jean-Paul Behr [2], affiliated with Université de Strasbourg [5] and University of Vienna [6], co-authored the same study 'A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine' [7], contributing to establishing practical gene-delivery approaches in tissue-engineering contexts. This contribution provided a means to modulate genetic signaling in cells within biomaterial matrices, enabling controlled differentiation, engraftment, and tissue assembly characteristic of the Biomaterials-Enabled Tissue Engineering era.

Biofabrication and ECM Bioprinting era

Shinya Yamanaka [1] is a pivotal figure in the Biofabrication and ECM Bioprinting era, with affiliations across the University of California, San Francisco [3] and Stanford University [4]. In this era, his key contribution was the 2007 paper Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts [7], which established a method to reprogram somatic cells into pluripotent states without c-Myc, enabling patient-specific cell sources and advancing the feasibility of engineered tissues. Masato Nakagawa [2] is associated with The University of Tokyo [5] and Kyoto University [6] in this era. Nakagawa's contributions in this era include co-authoring the 2007 paper Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts [7], which introduced reprogramming without Myc and advanced patient-specific cell production.